KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xwell (XWEL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Xwell (XWEL) over the last 17 years, with Q3 2025 value amounting to $4.0 million.

  • Xwell's Cash & Equivalents fell 865.98% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 865.98%. This contributed to the annual value of $4.6 million for FY2024, which is 4607.09% down from last year.
  • Xwell's Cash & Equivalents amounted to $4.0 million in Q3 2025, which was down 865.98% from $5.3 million recorded in Q2 2025.
  • Xwell's 5-year Cash & Equivalents high stood at $109.2 million for Q3 2021, and its period low was $3.6 million during Q1 2025.
  • Its 5-year average for Cash & Equivalents is $37.0 million, with a median of $8.4 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 256274.97% in 2021, then tumbled by 9103.05% in 2023.
  • Xwell's Cash & Equivalents (Quarter) stood at $105.5 million in 2021, then plummeted by 81.96% to $19.0 million in 2022, then tumbled by 55.68% to $8.4 million in 2023, then crashed by 46.07% to $4.6 million in 2024, then decreased by 12.37% to $4.0 million in 2025.
  • Its Cash & Equivalents stands at $4.0 million for Q3 2025, versus $5.3 million for Q2 2025 and $3.6 million for Q1 2025.